The mediating effects of barriers to vaccination on the relationship between race/ethnicity and influenza vaccination status in a rural Southeastern Louisiana medical center.
The mediating effects of barriers to vaccination on the relationship between race/ethnicity and influenza vaccination status in a rural Southeastern Louisiana medical center.
复制标题
DOI：
10.15167/2421-4248/jpmh2022.63.3.2687
复制
发表时间：
2022
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
在少数族裔和白人之间，流感疫苗接种率一直存在差异。定义这种关系的机制还没有得到充分研究。对路易斯安那州东南部一个乡村医疗中心的门诊患者进行了评估疫苗接种障碍的调查。调查回复与患者的医疗记录相匹配。利克特式的声明被用来衡量疫苗接种的障碍。对种族与流感疫苗接种障碍之间的关系进行了中介分析。调查对象自我报告的流感疫苗接种率为40.4%。白人(45.5%)比种族/少数民族(36.3%)更有可能报告接受了流感疫苗接种(p=0.02)。少数族裔报告的疫苗接种障碍得分显著较高(p<；0.01)。种族/民族与疫苗接种之间的关系是通过疫苗接种障碍进行调节的，当控制提供者的建议并且至少有一种共病疾病时(自然间接影响[NIE]p值=0.02，调节比例=0.71)。疫苗接种障碍调解了种族/族裔与疫苗接种状况之间的关系。供应商应专注于最大限度地减少对疫苗会导致疾病的担忧，并强调疫苗在预防严重流感相关疾病方面是安全有效的。应作出更多努力，改善流感疫苗的可获得性，包括解决疫苗接种费用问题，扩大提供疫苗的环境的数量和类型。
Persistent disparities in influenza vaccination rates exist between racial/ethnic minorities and Whites. The mechanisms that define this relationship are under-researched. Surveys assessing barriers to vaccination were administered to outpatients in a rural medical center in Southeastern Louisiana. Survey responses were matched to patient medical records. Likert-style statements were used to measure barriers to vaccination. A mediation analysis assessing the relationship between race and influenza vaccination mediated by vaccination barriers was conducted. The self-reported influenza vaccination rate in those surveyed was 40.4%. Whites (45.5%) were more likely than racial/ethnic minorities (36.3%) to report receipt of an influenza vaccination (p = 0.02). Racial/ethnic minorities reported significantly higher vaccination barrier scores (p < 0.01). The relationship between race/ethnicity and vaccination was mediated by vaccination barriers, when controlling for provider recommendation and having at least one comorbid medical condition (natural indirect effect [NIE] p-value = 0.02, proportion mediated = 0.71). Barriers to vaccination mediates the relationship between race/ethnicity and vaccination status. Providers should focus on minimizing fears that the vaccine will cause illness and emphasize that the vaccine is safe and effective at preventing severe influenza-associated illness. Additional efforts should be made to improve accessibility of the influenza vaccine, including addressing costs of vaccination and expanding the number and types of settings where the vaccine is offered.